Participation

Are you a woman 50 years or older? 

Have you had one or more of the following symptoms for longer than 2 weeks and less than one year:

  • Feeling full quickly (early satiety)?
  • Abdominal bloating and/or swelling?
  • Abdominal pain?
  • Vaginal discharge or bleeding?
  • Frequent need to urinate?

You may be eligible for the DOvEE project.

 

How does it work?

Determine your eligibility:

Call the DOvEE team to learn if you are eligible:

1-866-716-3267
514-934-1934, extension 39348

You can also complete the Online Eligibility Questionnaire (English or French) for a quick answer about your eligibility. If you are eligible, you can give us your contact information in order to participate in the DOvEE study and arrange your visits. Your answers will not commit you to any action, and will be destroyed if you decide not to participate.

If you are eligible, you will quickly be given an appointment for your first visit.

 

Your first visit 

 

Meeting with a healthcare professional to discuss the project and your medical history.
Blood test (CA-125).*

 

Number_2

Your second visit

(Two weeks after your first visit)
Appointment with a healthcare professional for a transvaginal ultrasound.

 
Number_3
 

Your third visit

(6 weeks after your first visit)
Repeated blood test (CA-125).*

Number_4
 

Follow-up

(6 months after your last visit)
Phone call to evaluate your health and ensure proper follow-up.

*CA-125 Blood test

This test determines the level of the tumour antigen 125 (CA-125) in the blood. Tumour antigen 125 is a protein produced by ovarian cancer cells. Finding the level of this protein in the blood can accompany early ovarian cancer detection.

 

The DOvEE Project is kindly funded by the Canadian Institutes of Health Research and the McGill University Health Centre.

Back to top